Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
April 8 (Reuters) - Mithra Pharmaceuticals SA
MITRA.BR :
* REACHES MILESTONE IN ESTETROL SKIN STUDY
* TOP-LINE RESULTS EXPECTED TO BE COMPLETED BY THE END OF
2024
WITH THE FINAL CLINICAL STUDY REPORT EXPECTED BY Q2 2025
* HAS ACHIEVED LAST PATIENT RANDOMIZED (LPR) IN THIS STUDY,
MARKING CULMINATION OF RECRUITMENT PHASE
Source text for Workspace: ID:nNDL1NQjnC
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 785 110;))
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO